drugset / Trial / NCT06268470

Antiplatelet Therapy in Chronic Urticaria

NCT06268470

Phase 2 Unknown 12 enrolled Chulalongkorn University
RandomizedParallel-groupTriple-blindTreatment

Summary

This study compares the combination of antiplatelets and antihistamine versus antihistamine alone for the treatment of chronic spontaneous urticaria

Timeline

Start
2018-06-01
Primary completion
2024-03-01
Completion
2024-05-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Cilostazol Small molecule 150 mg
Subject Desloratadine Small molecule 20 mg Oral
Subject Dipyridamole Other / unclassified 50 mg

Indications